Xilio Therapeutics, Inc. (XLO) Social Stream



Xilio Therapeutics, Inc. (XLO): $0.91

0.05 (-4.74%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add XLO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#79 of 347

in industry

XILIO THERAPEUTICS INC (XLO) Price Targets From Analysts

Use the tables below to see what analysts covering XILIO THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-04-12 5 $40 $31 $34.75 $0.68 5010.29%
2022-08-09 4 $40 $31 $34.333 $0.68 4948.97%
2022-08-10 4 $40 $20 $30.333 $0.68 4360.74%
2022-11-10 4 $40 $13 $24.333 $0.68 3478.38%
2022-12-21 4 $20 $7 $13.333 $0.68 1860.74%
2023-05-10 4 $13 $7 $10 $0.68 1370.59%
2023-08-14 3 $13 $10 $11.5 $0.68 1591.18%
2023-09-20 3 $13 $7 $10 $0.68 1370.59%
2023-11-10 3 $10 $6 $7.666 $0.68 1027.35%
2023-12-19 3 $7 $5 $6 $0.68 782.35%
NA 3 $NA $NA $NA $0.68 NA%

The Trend in the Analyst Price Target


Over the past 52 weeks, XLO's average price target has gone down $7.33.

XLO reports an average of 338.43% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-05 4 13 7 10.000 3.04 228.95%
2023-08-14 4 13 10 11.500 2.86 302.1%
2023-08-14 3 13 10 11.500 2.86 302.1%
2023-11-10 4 13 6 9.000 1.43 529.37%
2023-11-10 4 10 6 7.666 1.43 436.08%

XLO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


XLO's average broker recommendation rating improved by 0.5 over the prior 25 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, XILIO THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1378.79% of them.
  • XLO has a greater number of analysts covering the stock than 171.38% of all US stocks.
  • XLO has a higher average analyst price target than 384.64% of Healthcare stocks.
  • In terms of how XILIO THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -388.74% of that group.

Stocks similar to XILIO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LIAN, ANTX, and BLTE.

What is the outlook for XLO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!